Antipsychotic-Induced Constipation: A Review of the Pathogenesis, Clinical Diagnosis, and Treatment
- PMID: 34427901
- DOI: 10.1007/s40263-021-00859-0
Antipsychotic-Induced Constipation: A Review of the Pathogenesis, Clinical Diagnosis, and Treatment
Abstract
Antipsychotic-induced gastrointestinal hypomotility and, in particular, its manifestation of constipation are common adverse effects in patients with schizophrenia in clinical practice. Serious complications of antipsychotic-induced constipation include ileus, ischaemic bowel disease, colon perforation, aspiration pneumonia, and bacterial septicaemia, which can be life threatening if left untreated, especially in patients prescribed clozapine. The aim of this paper is to review the latest research on the epidemiology, clinical examination methods, pathophysiology, and treatment options and preventive measures for antipsychotic-induced constipation. While clinicians are normally aware of the overall side effects caused by antipsychotics, constipation is often an under-recognized condition despite its relatively high incidence and its impact on daily living. The incidence of constipation differs among individual antipsychotics, but more than 50% of patients prescribed antipsychotics suffer from constipation. Limited fluid intake, poor dietary habits, and a sedentary lifestyle can also worsen constipation. The mechanisms of antipsychotic-induced constipation may be antagonism of cholinergic, histaminergic, and serotonergic receptors, with both parent drug and metabolite(s) contributing to the effects on gastrointestinal motility. Numerous methods, mainly divided into scale evaluations and objective examinations, are applied to evaluate antipsychotic-induced constipation; however, objective examinations have a greater ability to identify cases of gastrointestinal hypomotility since there is often an under-reporting of symptoms in subjective reporting and scale evaluation due to a higher pain threshold, an inability to express pain sensations, and a lack of symptom awareness in these patients. Antipsychotic drug-induced constipation should be closely monitored in patients receiving these medications, with timely intervention to avoid serious gastrointestinal consequences. There is currently no consensus on the efficacy of laxatives in these patients. Further in-depth studies should explore the underlying mechanisms and devise optimal therapeutic approaches to minimize constipation during antipsychotic treatment.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Similar articles
-
Focussing on the fundaments - assessing and treating Clozapine Induced Gastrointestinal Hypomotility.Int J Psychiatry Clin Pract. 2020 Mar;24(1):18-19. doi: 10.1080/13651501.2019.1710538. Epub 2020 Jan 7. Int J Psychiatry Clin Pract. 2020. PMID: 31910056
-
Risk of gastrointestinal Hypomotility in schizophrenia and schizoaffective disorder treated with antipsychotics: A retrospective cohort study.Schizophr Res. 2018 May;195:237-244. doi: 10.1016/j.schres.2017.10.024. Epub 2017 Oct 27. Schizophr Res. 2018. PMID: 29107449
-
The Porirua Protocol in the Treatment of Clozapine-Induced Gastrointestinal Hypomotility and Constipation: A Pre- and Post-Treatment Study.CNS Drugs. 2017 Jan;31(1):75-85. doi: 10.1007/s40263-016-0391-y. CNS Drugs. 2017. PMID: 27826741
-
Second-generation antipsychotics and constipation: a review of the literature.Eur Psychiatry. 2011 Jan;26(1):34-44. doi: 10.1016/j.eurpsy.2010.03.003. Epub 2010 Jun 9. Eur Psychiatry. 2011. PMID: 20542667 Review.
-
Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases.J Clin Psychiatry. 2008 May;69(5):759-68. doi: 10.4088/jcp.v69n0509. J Clin Psychiatry. 2008. PMID: 18452342 Review.
Cited by
-
Paralytic ileus in a patient on clozapine therapy showing an inverted clozapine/norclozapine ratio after switching valproic acid to carbamazepine: a case report.Ther Adv Psychopharmacol. 2024 May 31;14:20451253241255487. doi: 10.1177/20451253241255487. eCollection 2024. Ther Adv Psychopharmacol. 2024. PMID: 38827014 Free PMC article.
-
Real-world evidence of constipation and laxative use in the Korean population with chronic kidney disease from a common data model.Sci Rep. 2024 Mar 19;14(1):6610. doi: 10.1038/s41598-024-57382-7. Sci Rep. 2024. PMID: 38503885 Free PMC article.
-
Evaluating Monitoring Guidelines of Clozapine-Induced Adverse Effects: a Systematic Review.CNS Drugs. 2024 Feb;38(2):105-123. doi: 10.1007/s40263-023-01054-z. Epub 2024 Jan 18. CNS Drugs. 2024. PMID: 38236524
-
Factors associated with the initiation of laxative use in the same patients with schizophrenia over a 20-year period: Retrospective cohort study.Neuropsychopharmacol Rep. 2024 Mar;44(1):60-66. doi: 10.1002/npr2.12378. Epub 2023 Sep 12. Neuropsychopharmacol Rep. 2024. PMID: 37698084 Free PMC article.
-
Efficacy and safety of electroacupuncture for secondary constipation: a systematic review and meta-analysis.Int J Colorectal Dis. 2023 Jul 15;38(1):196. doi: 10.1007/s00384-023-04487-6. Int J Colorectal Dis. 2023. PMID: 37452920 Free PMC article. Review.
References
-
- Stroup TS, Gray N. Management of common adverse effects of antipsychotic medications. World Psychiatry Off J World Psychiatr Assoc (WPA). 2018;17(3):341–56. https://doi.org/10.1002/wps.20567 . - DOI
-
- Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of rome foundation global study. Gastroenterology. 2020. https://doi.org/10.1053/j.gastro.2020.04.014 . - DOI - PubMed
-
- Chen HK, Hsieh CJ. Risk of gastrointestinal Hypomotility in schizophrenia and schizoaffective disorder treated with antipsychotics: a retrospective cohort study. Schizophr Res. 2018;195:237–44. https://doi.org/10.1016/j.schres.2017.10.024 . - DOI - PubMed
-
- Nielsen J, Meyer JM. Risk factors for ileus in patients with schizophrenia. Schizophr Bull. 2012;38(3):592–8. https://doi.org/10.1093/schbul/sbq137 . - DOI - PubMed
-
- Thomas N, Jain N, Connally F, Yeung JM, Pantelis C. Prucalopride in clozapine-induced constipation. Aust N Z J Psychiatry. 2018;52(8):804. https://doi.org/10.1177/0004867418774413 . - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical